Zhang Financial LLC purchased a new stake in Colgate-Palmolive (NYSE:CL – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 10,035 shares of the company’s stock, valued at approximately $912,000.
Several other large investors also recently made changes to their positions in CL. Peak Financial Advisors LLC bought a new stake in Colgate-Palmolive in the 4th quarter valued at approximately $1,315,000. Gordian Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the third quarter valued at approximately $602,000. Carrera Capital Advisors lifted its position in shares of Colgate-Palmolive by 23.1% in the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after purchasing an additional 7,353 shares in the last quarter. Vontobel Holding Ltd. boosted its holdings in Colgate-Palmolive by 224.6% during the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock worth $82,626,000 after purchasing an additional 550,750 shares during the last quarter. Finally, Fiduciary Alliance LLC bought a new position in Colgate-Palmolive in the fourth quarter valued at $4,066,000. Institutional investors own 80.41% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on CL shares. Stifel Nicolaus cut their price objective on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a report on Friday. UBS Group decreased their price objective on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research report on Thursday. JPMorgan Chase & Co. dropped their target price on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a report on Thursday. TD Cowen reduced their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. Finally, Wells Fargo & Company lowered their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $101.11.
Insider Buying and Selling at Colgate-Palmolive
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.37% of the company’s stock.
Colgate-Palmolive Stock Performance
Shares of Colgate-Palmolive stock opened at $88.79 on Monday. The company’s 50 day moving average price is $92.20 and its two-hundred day moving average price is $97.75. The firm has a market capitalization of $72.55 billion, a P/E ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44. Colgate-Palmolive has a fifty-two week low of $79.69 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.
Colgate-Palmolive Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- What Is WallStreetBets and What Stocks Are They Targeting?
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- What is a support level?
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
- What is a Stock Market Index and How Do You Use Them?
- There May Still Be Time to Get in on These 3 Trending Biotechs
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.